242 related articles for article (PubMed ID: 33940157)
1. Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies.
Djeddi S; Reiss D; Menuet A; Freismuth S; de Carvalho Neves J; Djerroud S; Massana-Muñoz X; Sosson AS; Kretz C; Raffelsberger W; Keime C; Dorchies OM; Thompson J; Laporte J
Mol Ther; 2021 Aug; 29(8):2514-2534. PubMed ID: 33940157
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen improves muscle structure and function of Bin1- and Dnm2-related centronuclear myopathies.
Gineste C; Simon A; Braun M; Reiss D; Laporte J
Brain; 2023 Jul; 146(7):3029-3048. PubMed ID: 36562127
[TBL] [Abstract][Full Text] [Related]
3. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
[TBL] [Abstract][Full Text] [Related]
4. MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy.
Giraud Q; Spiegelhalter C; Messaddeq N; Laporte J
Brain; 2023 Oct; 146(10):4158-4173. PubMed ID: 37490306
[TBL] [Abstract][Full Text] [Related]
5. Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.
Gómez-Oca R; Cowling BS; Laporte J
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768808
[TBL] [Abstract][Full Text] [Related]
6. Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.
Silva-Rojas R; Nattarayan V; Jaque-Fernandez F; Gomez-Oca R; Menuet A; Reiss D; Goret M; Messaddeq N; Lionello VM; Kretz C; Cowling BS; Jacquemond V; Laporte J
Mol Ther; 2022 Feb; 30(2):868-880. PubMed ID: 34371181
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
[TBL] [Abstract][Full Text] [Related]
8. Reducing dynamin 2 (DNM2) rescues
Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
[TBL] [Abstract][Full Text] [Related]
9. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
[TBL] [Abstract][Full Text] [Related]
10. Centronuclear myopathies: a widening concept.
Romero NB
Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
[TBL] [Abstract][Full Text] [Related]
11. The myotubularin-amphiphysin 2 complex in membrane tubulation and centronuclear myopathies.
Royer B; Hnia K; Gavriilidis C; Tronchère H; Tosch V; Laporte J
EMBO Rep; 2013 Oct; 14(10):907-15. PubMed ID: 23917616
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathy.
Gayi E; Neff LA; Massana Muñoz X; Ismail HM; Sierra M; Mercier T; Décosterd LA; Laporte J; Cowling BS; Dorchies OM; Scapozza L
Nat Commun; 2018 Nov; 9(1):4848. PubMed ID: 30451843
[TBL] [Abstract][Full Text] [Related]
13. Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice.
Lionello VM; Nicot AS; Sartori M; Kretz C; Kessler P; Buono S; Djerroud S; Messaddeq N; Koebel P; Prokic I; Hérault Y; Romero NB; Laporte J; Cowling BS
Sci Transl Med; 2019 Mar; 11(484):. PubMed ID: 30894500
[TBL] [Abstract][Full Text] [Related]
14. Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.
Tasfaout H; Lionello VM; Kretz C; Koebel P; Messaddeq N; Bitz D; Laporte J; Cowling BS
Mol Ther; 2018 Apr; 26(4):1082-1092. PubMed ID: 29506908
[TBL] [Abstract][Full Text] [Related]
15. Amphiphysin (BIN1) negatively regulates dynamin 2 for normal muscle maturation.
Cowling BS; Prokic I; Tasfaout H; Rabai A; Humbert F; Rinaldi B; Nicot AS; Kretz C; Friant S; Roux A; Laporte J
J Clin Invest; 2017 Dec; 127(12):4477-4487. PubMed ID: 29130937
[TBL] [Abstract][Full Text] [Related]
16. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
[TBL] [Abstract][Full Text] [Related]
17. Novel molecular diagnostic approaches for X-linked centronuclear (myotubular) myopathy reveal intronic mutations.
Tosch V; Vasli N; Kretz C; Nicot AS; Gasnier C; Dondaine N; Oriot D; Barth M; Puissant H; Romero NB; Bönnemann CG; Heller B; Duval G; Biancalana V; Laporte J
Neuromuscul Disord; 2010 Jun; 20(6):375-81. PubMed ID: 20434914
[TBL] [Abstract][Full Text] [Related]
18. Adult-onset autosomal dominant centronuclear myopathy due to BIN1 mutations.
Böhm J; Biancalana V; Malfatti E; Dondaine N; Koch C; Vasli N; Kress W; Strittmatter M; Taratuto AL; Gonorazky H; Laforêt P; Maisonobe T; Olivé M; Gonzalez-Mera L; Fardeau M; Carrière N; Clavelou P; Eymard B; Bitoun M; Rendu J; Fauré J; Weis J; Mandel JL; Romero NB; Laporte J
Brain; 2014 Dec; 137(Pt 12):3160-70. PubMed ID: 25260562
[TBL] [Abstract][Full Text] [Related]
19. Symptomatic heterozygous X-Linked myotubular myopathy female patient with a large deletion at Xq28 and decrease expression of normal allele.
Gómez-González C; Rosas-Alonso R; Rodríguez-Antolín C; García-Guede A; Ibáñez de Caceres I; Sanguino J; Pascual SI; Esteban I; Pozo AD; Mori MÁ; Torres RJ; Prior C
Eur J Med Genet; 2021 Apr; 64(4):104170. PubMed ID: 33618039
[TBL] [Abstract][Full Text] [Related]
20. Dynamin 2 the rescue for centronuclear myopathy.
Demonbreun AR; McNally EM
J Clin Invest; 2014 Mar; 124(3):976-8. PubMed ID: 24569368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
